Informativa e consenso per l'uso dei cookie

Accetto Il nostro sito salva piccoli pezzi di informazioni (cookie) sul dispositivo, al fine di fornire contenuti migliori e per scopi statistici. È possibile disattivare l'utilizzo di cookies modificando le impostazioni del tuo browser. Continuando la navigazione si acconsente all'utilizzo dei cookie.

443797-96-4 - Aurora Kinase/Cdk Inhibitor - 4-(5-Amino-1-(2,6-difluorobenzoyl)-1H-[1,2,4]triazol-3-ylamino)-benzenesulfonamide - J65997 - Alfa Aesar

J65997 Aurora Kinase/Cdk Inhibitor

Codice CAS
443797-96-4
Sinonimi
4-(5-Amino-1-(2,6-difluorobenzoyl)-1H-[1,2,4]triazol-3-ylamino)-benzenesulfonamide

Dimensioni Prezzo ($) Quantità Disponibilità
5mg 377,00
Aggiungi al carrello Aggiungi al preventivo generale Visualizza articolo

Aurora Kinase/Cdk Inhibitor

MDL
MFCD11100270

Proprietà chimiche

Formula
C15H12F2N6O3S.CH3CN
Peso formula
435.41
Modulo
Powder
Sensibilità
Light Sensitive
Solubilità
Soluble in DMSO at 15mg/ml

Applicazioni

Aurora Kinase/Cdk Inhibitor is a broad spectrum inhibitor of cyclin-dependent kinases and aurora kinases including CDK1/Cyclin B, CDK2/Cyclin A, CDK2/Cyclin E, Aurora-A and Aurora-B. It as been shown to induce growth suppression and mitotic defects, these results suggest that Aurora Kinase/Cdk Inhibitor could be useful for cell cycle analysis and therapy of various cancers, including Ewing's sarcoma.

Note

Light Sensitive, store in dark. Keep the container tightly closed. Store away from oxidizing agent. Store under dry inert gas.

Letteratura

Emanuel, S.et al. The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases. Cancer Res., 2005,65(19), 9038-9046.

Lin, R. et al. 1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activities. J Med Chem., 2005,48(13), 4208-11.

Rischio GHS e dichiarazioni precauzionali

Dichiarazioni di rischio (UE): H302-H315-H319-H335

Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.

Dichiarazioni precauzionali: P260u-P201-P280a-P303+P361+P353-P305+P351+P338-P301+P330+P331-P304+P340-P310a-P405-P501a

Obtain special instructions before use. Wear protective gloves and eye/face protection. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Altri riferimenti

Codice tariffe armonizzato
3504.00
TSCA
No

Raccomandato

  • H27314

    7-Bromoacetyl-3,4-dihydro-1,5-benzodioxepin, 97%
  • L04928

    Hexaphenyldisilane, 98%
  • 13806

    Silver single crystal disc, 10mm (0.39in) dia, 1-3mm (0.04-0.1in) thick, (110) orientation
  • H53008

    3-(4-Methyl-1-piperazinylcarbonyl)benzeneboronic acid hydrochloride, 98%
  • B23565

    2-Chloro-4-fluorobenzyl bromide, 97%

Visualizzati di recente

Prodotti chimici

Scienze della vita

Metalli e materiali

Catalizzatori

Apparecchiature di analisi e di laboratorio